$1.20
9.77% today
Nasdaq, Nov 17, 09:43 pm CET
ISIN
US7168174081
Symbol
PETV

PetVivo Holdings Inc Stock price

$1.20
-0.15 11.11% 1M
+0.50 71.43% 6M
+0.58 93.55% YTD
+0.67 125.14% 1Y
-7.30 85.88% 3Y
-4.20 77.78% 5Y
-16.40 93.18% 10Y
-85.69 98.62% 20Y
Nasdaq, Closing price Mon, Nov 17 2025
-0.13 9.77%

Key metrics

Basic
Market capitalization
$37.1m
Enterprise Value
$38.4m
Net debt
$1.3m
Cash
$30.0k
Shares outstanding
21.3m
Valuation (TTM | estimate)
P/E
negative | -
P/S
38.7 | 1.0
EV/Sales
40.0 | 1.1
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
22.0%
Return on Equity
-1,597.2%
ROCE
-5,073.4%
ROIC
-
Debt/Equity
-1.9
Financials (TTM | estimate)
Revenue
$960.0k | $8.9m
EBITDA
$-8.5m | -
EBIT
$-8.6m | -
Net Income
$-8.6m | -
Free Cash Flow
$-5.7m
Growth (TTM | estimate)
Revenue
-8.6% | 817.5%
EBITDA
16.6% | -
EBIT
16.2% | -
Net Income
18.8% | -
Free Cash Flow
25.1%
Margin (TTM | estimate)
Gross
108.5%
EBITDA
-888.3% | -
EBIT
-902.1%
Net
-902.7% | -
Free Cash Flow
-594.9%
More
EPS
$-0.4
FCF per Share
$-0.3
Short interest
1.0%
Employees
24
Rev per Employee
$40.0k
Show more

Is PetVivo Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

PetVivo Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a PetVivo Holdings Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a PetVivo Holdings Inc forecast:

Buy
86%
Hold
14%

Financial data from PetVivo Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.96 0.96
9% 9%
100%
- Direct Costs -0.08 -0.08
116% 116%
-8%
1.04 1.04
96% 96%
108%
- Selling and Administrative Expenses 7.87 7.87
21% 21%
820%
- Research and Development Expense 1.80 1.80
96% 96%
188%
-8.49 -8.49
17% 17%
-884%
- Depreciation and Amortization 0.13 0.13
18% 18%
14%
EBIT (Operating Income) EBIT -8.62 -8.62
16% 16%
-898%
Net Profit -8.63 -8.63
19% 19%
-899%

In millions USD.

Don't miss a Thing! We will send you all news about PetVivo Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PetVivo Holdings Inc Stock News

Neutral
Seeking Alpha
3 days ago
PetVivo Holdings, Inc. (OTCPK:PETV) Q2 2026 Earnings Call November 14, 2025 5:00 PM EST Company Participants John Dolan - General Counsel, Chief Business Development Officer & Secretary Garry Lowenthal - Chief Financial Officer Michael Eldred - Commercialization & Operations Advisor and Executive Director John Lai - CEO, President & Director Presentation John Dolan General Counsel, Chief Busine...
Neutral
GlobeNewsWire
3 days ago
MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its second quarter and first half of fiscal year 2026 ended September 30, 2025.
Neutral
GlobeNewsWire
10 days ago
MINNEAPOLIS, MN, US, Nov. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary Petvivo Animal Health, Inc., a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, November 14, 2025 at 5:00 p.m. Eastern time to discuss results for the f...
More PetVivo Holdings Inc News

Company Profile

PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.

Head office United States
CEO John Lai
Employees 24
Founded 2009
Website petvivo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today